|
(Details) (Gain (Loss) from Foreign Currency Forward Contracts) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 28, 2013
|
Sep. 29, 2012
|
Sep. 28, 2013
|
Sep. 29, 2012
|
|
| Foreign Currency Forward Contracts, Gain (Loss) [Line Items] | ||||
| Research and Development Expense | $ (288) | $ (328) | $ (908) | $ (1,041) |
|
Contracts designated as cash flow hedging instruments
|
||||
| Foreign Currency Forward Contracts, Gain (Loss) [Line Items] | ||||
| Other comprehensive income (loss) | 3 | 3 | (1) | 4 |
| Research and Development Expense | (1) | 0 | (1) | (1) |
|
Contracts not designated as hedging instruments
|
||||
| Foreign Currency Forward Contracts, Gain (Loss) [Line Items] | ||||
| Other income (expense), net | $ 1 | $ 2 | $ (1) | $ 2 |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|